iSpecimen Inc.
ISPCNASDAQHealthcare● Active
$2.95
$-0.07(-2.32%)
Market Cap$409643
P/E Ratio—
52W High$127.2
52W Low$2.9
iSpecimen Inc. (ISPC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ISPC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$6.66
Revenue
$0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
🔥 4-Quarter EPS Beat Streak
ISPC reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 15, 2026 | — | -$6.66 | — | $0.00B | — | — |
| ▲ Q2 FY2026 | Apr 1, 2026 | -$152.00 | -$23.60 | +84.5% | $0.00B | $0.00B | -98.5% |
| ▲ Q4 FY2025 | Nov 17, 2025 | -$3.80 | -$0.48 | +87.4% | $0.00B | $0.00B | -96.8% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$3.80 | -$0.42 | +89.0% | $0.00B | $0.00B | -77.0% |
| ▲ Q2 FY2025 | May 19, 2025 | -$4.40 | -$0.71 | +83.9% | $0.00B | $0.00B | -58.5% |
| ▼ Q2 FY2025 | Apr 14, 2025 | -$4.00 | -$6.28 | -57.0% | $0.00B | $0.00B | -50.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$3.80 | -$2.10 | +44.7% | $0.00B | $0.00B | -9.7% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026
EPS Actual
-$6.66
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2026
Apr 1, 2026Beat
EPS Actual
-$23.60
EPS Est.
-$152.00
EPS Surpr.
+84.5%
Revenue
$0.00B
Q4 FY2025
Nov 17, 2025Beat
EPS Actual
-$0.48
EPS Est.
-$3.80
EPS Surpr.
+87.4%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.42
EPS Est.
-$3.80
EPS Surpr.
+89.0%
Revenue
$0.00B
Q2 FY2025
May 19, 2025Beat
EPS Actual
-$0.71
EPS Est.
-$4.40
EPS Surpr.
+83.9%
Revenue
$0.00B
Q2 FY2025
Apr 14, 2025Miss
EPS Actual
-$6.28
EPS Est.
-$4.00
EPS Surpr.
-57.0%
Revenue
$0.00B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$2.10
EPS Est.
-$3.80
EPS Surpr.
+44.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-152.00 | $-152.00 | $-152.00 | 1 |
| Q3 FY2025 | $-152.00 | $-152.00 | $-152.00 | 1 |
| Q2 FY2025 | $-152.00 | $-152.00 | $-152.00 | 1 |
| Q1 FY2025 | $-176.00 | $-176.00 | $-176.00 | 1 |
| Q4 FY2024 | $-160.00 | $-160.00 | $-160.00 | 1 |
| Q3 FY2024 | $-152.00 | $-152.00 | $-152.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | $3.97 | $4.15 | +4.53% |
| ▲ Q2 FY2026 | Apr 1, 2026 | +84.5% | $6.28 | $6.08 | -3.18% |
| ▲ Q4 FY2025 | Nov 17, 2025 | +87.4% | $25.10 | $23.21 | -7.53% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +89.0% | $46.40 | $46.80 | +0.86% |
| ▲ Q2 FY2025 | May 19, 2025 | +83.9% | $45.20 | $46.80 | +3.54% |
| ▼ Q2 FY2025 | Apr 14, 2025 | -57.0% | $48.80 | $50.80 | +4.10% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +44.7% | $177.60 | $197.60 | +11.26% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +32.1% | $190.80 | $200.00 | +4.82% |
Q2 FY2026+4.53%
Report Date
May 15, 2026
EPS Beat/Miss
—
Price Before
$3.97
Price After
$4.15
Q2 FY2026-3.18%
Report Date
Apr 1, 2026
EPS Beat/Miss
+84.5%
Price Before
$6.28
Price After
$6.08
Q4 FY2025-7.53%
Report Date
Nov 17, 2025
EPS Beat/Miss
+87.4%
Price Before
$25.10
Price After
$23.21
Q3 FY2025+0.86%
Report Date
Aug 14, 2025
EPS Beat/Miss
+89.0%
Price Before
$46.40
Price After
$46.80
Q2 FY2025+3.54%
Report Date
May 19, 2025
EPS Beat/Miss
+83.9%
Price Before
$45.20
Price After
$46.80
Q2 FY2025+4.10%
Report Date
Apr 14, 2025
EPS Beat/Miss
-57.0%
Price Before
$48.80
Price After
$50.80
Q4 FY2024+11.26%
Report Date
Nov 7, 2024
EPS Beat/Miss
+44.7%
Price Before
$177.60
Price After
$197.60
Q3 FY2024+4.82%
Report Date
Aug 6, 2024
EPS Beat/Miss
+32.1%
Price Before
$190.80
Price After
$200.00
Avg Beat Reaction+1.63%
Avg Miss Reaction+4.10%
Beat Rate6 / 8 quarters
Largest Move+11.26% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ISPC ends December
iSpecimen Inc. (ISPC) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-6.66 (in line with the analyst consensus of —). ISPC has beaten EPS estimates for 4 consecutive quarters. The next ISPC earnings date is expected around September 1, 2026.
Each quarter, investors track ISPC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ISPC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ISPC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ISPC earnings · 4 questionsiSpecimen Inc.'s next earnings report is expected around September 1, 2026. ISPC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ISPC historically reports after market close (AMC).
ISPC earnings datewhen is ISPC earningsISPC next earnings datewhen does ISPC report earningsISPC earnings calendar
▸ Source: FMP · iSpecimen Inc. SEC filings · US GAAP · iSpecimen Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026